David E. Williams is President of the Health Business Group, a consulting firm that helps technology-enabled healthcare, medical device and pharmaceutical companies develop and execute innovative business strategies. He leads consulting teams, advises CEOs, is a member of corporate and non-profit boards, and chairs review panels for the federal government. He co-founded the company in 2003 after more than a decade as a consultant for the Boston Consulting Group and The LEK Partnership.
David has a rare ability to explain complex healthcare concepts simply and clearly, making him a sought after expert for media such as NPR, Business Week, US News and The Boston Globe. David produces the popular Health Business Blog, where he has written more than 4000 posts since 2005 and conducted more than 100 podcast interviews with entrepreneurs, executives, scientists and political leaders. During the Massachusetts gubernatorial race, he interviewed all nine candidates about health policy.
From Boston Business Journal, Atrius Health, state's largest independent physician group, is in acquisition talks, January 12, 2021
"As a physician-led organization, Atrius can make a strong impact on healthcare quality and cost," said David Williams, president of the Health Business Group, a Boston-based consulting firm. "But they need a strong balance sheet to play against (the state's largest hospital groups) Mass General Brigham and BI Lahey. With backing from Optum, Atrius will be able to be a strong force in Eastern Massachusetts and have the ability to enter into meaningful, value-based contracts with private insurers, Medicare and Medicaid."14 January 2021
From the Boston Globe: Biden, public health critics slam slower-than-promised pace of US COVID-19 vaccination rollout. "This should be D-Day right now," said one expert. But it's not. December 29, 2020
"Speed is what matters,” said David Williams, president of Health Business Group, a Boston management consulting firm. “This should be D-Day right now. But what’s happening nationally is it’s just being done in a bureaucratic manner and it’s not being done with the urgency you’d do in a civil defense or war-time exercise.”
Williams cited Oxford University data showing Israel, with a population not much bigger than Massachusetts, already has administered 5.68 doses per 100 people compared to the US total of 0.64 per 100.29 December 2020
From The Boston Globe: Beth Israel Lahey Health plans to acquire Joslin Diabetes Center, November 12, 2020
Joslin provides outpatient care; it is not a hospital. And while its specialty, diabetes, is a significant and widespread condition, it’s not a lucrative segment of health care because it doesn’t involve expensive procedures, noted David E. Williams, president of the consulting firm Health Business Group.
Williams said a deal with Beth Israel Lahey could help Joslin draw patients and is likely not big enough to worry regulators.
“There’s a question about if Joslin really could be viable on its own,” he said.20 November 2020